These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 1907409)

  • 1. Identity of a biliary metabolite formed from monocrotaline in isolated, perfused rat liver.
    Mattocks AR; Croswell S; Jukes R; Huxtable RJ
    Toxicon; 1991; 29(4-5):409-15. PubMed ID: 1907409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biliary excretion of novel pneumotoxic metabolites of the pyrrolizidine alkaloid, monocrotaline.
    Lafranconi WM; Ohkuma S; Huxtable RJ
    Toxicon; 1985; 23(6):983-92. PubMed ID: 3938082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The comparative metabolism of the four pyrrolizidine alkaloids, seneciphylline, retrorsine, monocrotaline, and trichodesmine in the isolated, perfused rat liver.
    Yan CC; Cooper RA; Huxtable RJ
    Toxicol Appl Pharmacol; 1995 Aug; 133(2):277-84. PubMed ID: 7645024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation and identification of a pyrrolic glutathione conjugate metabolite of the pyrrolizidine alkaloid monocrotaline.
    Lamé MW; Morin D; Jones AD; Segall HJ; Wilson DW
    Toxicol Lett; 1990 May; 51(3):321-9. PubMed ID: 2111054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic glutathione concentrations and the release of pyrrolic metabolites of the pyrrolizidine alkaloid, monocrotaline, from the isolated perfused liver.
    Nigra L; Huxtable RJ
    Toxicon; 1992 Oct; 30(10):1195-202. PubMed ID: 1440625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formation of DHP-derived DNA adducts from metabolic activation of the prototype heliotridine-type pyrrolizidine alkaloid, heliotrine.
    Xia Q; Yan J; Chou MW; Fu PP
    Toxicol Lett; 2008 May; 178(2):77-82. PubMed ID: 18395999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trapping of short-lived electrophilic metabolites of pyrrolizidine alkaloids escaping from perfused rat liver.
    Mattocks AR; Legg RF; Jukes R
    Toxicol Lett; 1990 Nov; 54(1):93-9. PubMed ID: 2244344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitation of the hepatic release of metabolites of the pyrrolizidine alkaloid, monocrotaline.
    Yan CC; Huxtable RJ
    Toxicol Appl Pharmacol; 1994 Jul; 127(1):58-63. PubMed ID: 8048054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of sulphur-conjugated pyrrolic metabolites in blood and fresh or fixed liver tissue from rats given a variety of toxic pyrrolizidine alkaloids.
    Mattocks AR; Jukes R
    Toxicol Lett; 1992 Oct; 63(1):47-55. PubMed ID: 1412522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between glutathione concentration and metabolism of the pyrrolizidine alkaloid, monocrotaline, in the isolated, perfused liver.
    Yan CC; Huxtable RJ
    Toxicol Appl Pharmacol; 1995 Jan; 130(1):132-9. PubMed ID: 7839360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism of [14C]monocrotaline by isolated perfused rat liver.
    Lamé MW; Jones AD; Morin D; Segall HJ
    Drug Metab Dispos; 1991; 19(2):516-24. PubMed ID: 1676664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between the concentration of the pyrrolizidine alkaloid monocrotaline and the pattern of metabolites released from the isolated liver.
    Yan CC; Huxtable RJ
    Toxicol Appl Pharmacol; 1995 Jan; 130(1):1-8. PubMed ID: 7839357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Covalent interaction of dehydroretronecine, a carcinogenic metabolite of the pyrrolizidine alkaloid monocrotaline, with cysteine and glutathione.
    Robertson KA; Seymour JL; Hsia MT; Allen JR
    Cancer Res; 1977 Sep; 37(9):3141-4. PubMed ID: 884667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human liver microsomal reduction of pyrrolizidine alkaloid N-oxides to form the corresponding carcinogenic parent alkaloid.
    Wang YP; Yan J; Fu PP; Chou MW
    Toxicol Lett; 2005 Mar; 155(3):411-20. PubMed ID: 15649625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Excretion of pyrrolic metabolites in the bile of rats given the pyrrolizidine alkaloid retrorsine or the bis-N-ethylcarbamate of synthanecine A.
    White IN
    Chem Biol Interact; 1977 Feb; 16(2):169-80. PubMed ID: 849622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic activation of pyrrolizidine alkaloids by human, rat and avocado microsomes.
    Couet CE; Hopley J; Hanley AB
    Toxicon; 1996 Sep; 34(9):1058-61. PubMed ID: 8896199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of taurine on biliary metabolites of glutathione in liver perfused with the pyrrolizidine alkaloid, monocrotaline.
    Yan CC; Huxtable RJ
    Adv Exp Med Biol; 1998; 442():85-9. PubMed ID: 9635018
    [No Abstract]   [Full Text] [Related]  

  • 18. Release of an alkylating metabolite, dehydromonocrotaline, from the isolated liver perfused with the pyrrolizidine alkaloid, monocrotaline.
    Yan CC; Huxtable RJ
    Proc West Pharmacol Soc; 1994; 37():107-8. PubMed ID: 7984635
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of the pyrrolizidine alkaloid, monocrotaline, on bile composition of the isolated, perfused rat liver.
    Yan CC; Huxtable RJ
    Life Sci; 1995; 57(6):617-26. PubMed ID: 7623629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 9-Glutathionyl-6,7-dihydro-1-hydroxymethyl-5H-pyrrolizine Is the Major Pyrrolic Glutathione Conjugate of Retronecine-Type Pyrrolizidine Alkaloids in Liver Microsomes and in Rats.
    Chen M; Li L; Zhong D; Shen S; Zheng J; Chen X
    Chem Res Toxicol; 2016 Feb; 29(2):180-9. PubMed ID: 26761523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.